Cargando…
OR29-2 Mild Autonomous Cortisol Excess (MACE) in Adrenal Incidentalomas - Metabolic Risk Profile and Urinary Steroid Metabolome Analysis in 1208 Prospectively Recruited Patients
BACKGROUND: Adrenal incidentalomas (AI) are frequently associated with mild autonomous cortisol excess (MACE). The 1mg-dexamethasone suppression test (1mg-DST) differentiates MACE into MACE-1 (possible MACE; post-Dex cortisol 50-138 nmol/L) and MACE-2 (definitive MACE; post-Dex cortisol >138 nmol...
Autores principales: | Prete, Alessandro, Taylor, Angela, Alice, Sitch, Gilligan, Lorna, Vassiliadi, Dimitra, Ambroziak, Urszula, Lang, Katharina, Kastelan, Darko, Tabarin, Antoine, Dennedy, Michael, Ueland, Grethe, Quinkler, Marcus, Masjkur, Jimmy, Fassnacht, Martin, Ivovic, Miomira, Terzolo, Massimo, Beuschlein, Felix, Manolopoulos, Konstantinos, O'Reilly, Michael, Tsagarakis, Stylianos, Shackleton, Cedric, Deeks, Jonathan, Bancos, Irina, Arlt, Wiebke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554888/ http://dx.doi.org/10.1210/js.2019-OR29-2 |
Ejemplares similares
-
Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study
por: Bancos, Irina, et al.
Publicado: (2020) -
Urine Steroid Metabolomics as a Novel Tool for Detection of Recurrent Adrenocortical Carcinoma
por: Chortis, Vasileios, et al.
Publicado: (2019) -
OR25-05 Increased Overall Mortality and Cardiovascular Morbidity in Patients with Adrenal Incidentalomas and Autonomous Cortisol Secretion: Results of the ENS@T NAPACA-Outcome Study
por: Deutschbein, Timo, et al.
Publicado: (2020) -
Diagnostic testing of autonomous cortisol secretion in adrenal incidentalomas
por: Ueland, Grethe Å, et al.
Publicado: (2020) -
Is Follow-up of Adrenal Incidentalomas Always Mandatory?
por: Reimondo, Giuseppe, et al.
Publicado: (2020)